Others have shown PMCA2 deficiency leads to increased sensitivity to Ca2+-induced apoptosis19, and we hypothesized that PMCA2 suppression may enhance the effects of cytotoxic chemotherapy on breast cancer cells. The gene discussed is ATP2B2; the disease is breast carcinoma.